These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8835576)

  • 1. Temporal association between the use of methotrexate and development of leukemia in 2 patients with rheumatoid arthritis.
    Dubin Kerr L; Troy K; Isola L
    J Rheumatol; 1995 Dec; 22(12):2356-8. PubMed ID: 8835576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of methotrexate induced lymphomas in rheumatoid arthritis: an association with increased serum IgE.
    Kono H; Inokuma S; Matsuzaki Y; Nakayama H; Yamazaki J; Hishima T; Maeda Y
    J Rheumatol; 1999 Oct; 26(10):2249-53. PubMed ID: 10529149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukemia after low dose methotrexate therapy in a patient with rheumatoid arthritis.
    Pointud P; Prudat M; Peron JM
    J Rheumatol; 1993 Jul; 20(7):1215-6. PubMed ID: 8371222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate.
    Usman AR; Yunus MB
    J Rheumatol; 1996 Jun; 23(6):1095-7. PubMed ID: 8782146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
    Ideguchi H; Ohno S; Ishigatsubo Y
    J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
    Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
    J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukoencephalopathy in a patient taking low dose oral methotrexate therapy for rheumatoid arthritis.
    Worthley SG; McNeil JD
    J Rheumatol; 1995 Feb; 22(2):335-7. PubMed ID: 7738959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon?
    Bruyn GA; Velthuysen E; Joosten P; Houtman PM
    J Rheumatol; 1995 Jul; 22(7):1373-6. PubMed ID: 7562775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoma in a patient with rheumatoid arthritis receiving methotrexate treatment: successful treatment with rituximab.
    Stewart M; Malkovska V; Krishnan J; Lessin L; Barth W
    Ann Rheum Dis; 2001 Sep; 60(9):892-3. PubMed ID: 11502618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis].
    Nakazaki S; Murayama T; Katoh S
    Ryumachi; 2001 Dec; 41(6):929-37. PubMed ID: 11831013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
    Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
    Miyazaki T; Fujimaki K; Shirasugi Y; Yoshiba F; Ohsaka M; Miyazaki K; Yamazaki E; Sakai R; Tamaru J; Kishi K; Kanamori H; Higashihara M; Hotta T; Ishigatsubo Y
    Am J Hematol; 2007 Dec; 82(12):1106-9. PubMed ID: 17654684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.